Bioorganic and Medicinal Chemistry Letters p. 1801 - 1806 (1999)
Update date:2022-07-30
Topics:
Keenan, Richard M.
Miller, William H.
Barton, Linda S.
Bondinell, William E.
Cousins, Russell D.
Eppley, Daniel F.
Hwang, Shing-Mei
Kwon, Chet
Lago, M. Amparo
Nguyen, Thomas T.
Smith, Brian R.
Uzinskas, Irene N.
Yuan, Catherine C. K.
A peptide RGD analog containing a novel 2-aminopyridine arginine mimetic was discovered to have good affinity and selectivity for the vitronectin receptor. Incorporation of the 2-aminopyridine arginine mimetic into the 3- oxo-1,4-benzodiazepine-2-acetic acid integrin antagonist series led to novel and potent nonpeptide vitronectin receptor antagonists with promising levels of oral bioavailability.
View MoreChemsky（shanghai）International Co.,Ltd.
Contact:0
Address:0
Shuanghe Bio-Technology Limited(expird)
Contact:+86-571-61710758,18968016640
Address:Jinqiao north road 916# Fuyang
Changzhou Ansciep Chemical Co.,Ltd.
Contact:+86 519 8630 5871
Address:A-710 Boan International, 8 East Guangdian Road,Wujin,Changzhou
Dongtai Xinyuan Chemical Co., Ltd.
Contact:+86-21-56733000
Address:404F, 99Nong No.117 Zhongtan Rd. Shanghai
ShangHai Ruiyi Medical Technology Co.,Ltd.
Contact:+86-21-54718086
Address:No951 Jianchuan RD，Minhang District
Doi:10.1016/j.bmc.2009.02.046
(2009)Doi:10.1021/ja01502a082
(1960)Doi:10.1246/bcsj.61.857
(1988)Doi:10.1021/ol900592b
(2009)Doi:10.1016/j.tet.2009.01.089
(2009)Doi:10.1039/b818445c
(2009)
